We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+3.66%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$9.03B
AUM Growth
+$1.87B
(+26%)
Cap. Flow
+$1.68B
Cap. Flow
% of AUM
18.63%
Top 10 Holdings %
Top 10 Hldgs %
13.82%
Holding
1,787
New
329
Increased
1,367
Reduced
42
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$58.9M |
| 2 |
Microsoft
MSFT
|
+$45.4M |
| 3 |
Amazon
AMZN
|
+$30.9M |
| 4 |
Meta Platforms (Facebook)
META
|
+$28.6M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$2M |
| 2 |
ProShares Merger ETF
MRGR
|
+$1.93M |
| 3 |
Alcoa
AA
|
+$1.78M |
| 4 |
RALS
ProShares RAFI Long/Short
RALS
|
+$1.32M |
| 5 |
WFM
Whole Foods Market Inc
WFM
|
+$1.24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.42% |
| 2 | Healthcare | 14.55% |
| 3 | Technology | 12.09% |
| 4 | Consumer Staples | 11.44% |
| 5 | Industrials | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Bank of Hawaii
BOH
$3.33B
| $945K | 0.01% |
10,656
+1,058
| +11% | +$85.8K |
|
802
Coherus Oncology
CHRS
$217M
| $945K | 0.01% |
33,575
+2,715
| +9% | +$76K |
|
803
Maximus
MMS
$3.14B
| $941K | 0.01% |
16,870
+5,204
| +45% | +$283K |
|
|
PRXL
804
DELISTED
Parexel International Corp
PRXL
| $941K | 0.01% |
14,317
+4,245
| +42% | +$266K |
|
805
Ciena
CIEN
$55.3B
| $938K | 0.01% |
38,437
+11,962
| +45% | +$261K |
|
|
EGRX
806
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $936K | 0.01% |
11,795
+902
| +8% | +$65.5K |
|
|
ASRT
807
DELISTED
Assertio
ASRT
| $935K | 0.01% |
864
+84
| +11% | +$107K |
|
808
First American
FAF
$7.67B
| $933K | 0.01% |
25,479
+2,244
| +10% | +$86K |
|
809
Harley-Davidson
HOG
$2.68B
| $927K | 0.01% |
15,890
+3,281
| +26% | +$187K |
|
810
Cracker Barrel
CBRL
$1.2B
| $926K | 0.01% |
5,545
+1,623
| +41% | +$245K |
|
811
Innoviva
INVA
$1.58B
| $926K | 0.01% |
86,535
+8,514
| +11% | +$89.4K |
|
812
Associated Banc-Corp
ASB
$5.81B
| $925K | 0.01% |
37,455
+4,163
| +13% | +$91.6K |
|
813
Deluxe
DLX
$1.19B
| $921K | 0.01% |
12,862
+3,945
| +44% | +$265K |
|
814
International Bancshares
IBOC
$4.77B
| $920K | 0.01% |
22,552
+4,665
| +26% | +$166K |
|
815
Ingredion
INGR
$6.38B
| $917K | 0.01% |
7,340
+1,346
| +22% | +$170K |
|
|
AVXS
816
DELISTED
AveXis, Inc. Common Stock
AVXS
| $917K | 0.01% |
+19,217
| New | +$1.03M |
|
817
Outfront Media
OUT
$5.64B
| $916K | 0.01% |
37,422
+5,700
| +18% | +$131K |
|
818
Glacier Bancorp
GBCI
$6.55B
| $911K | 0.01% |
25,137
+5,430
| +28% | +$175K |
|
|
NUVA
819
DELISTED
NuVasive, Inc.
NUVA
| $911K | 0.01% |
13,521
+3,981
| +42% | +$257K |
|
820
Murphy Oil
MUR
$5.58B
| $910K | 0.01% |
29,247
+4,576
| +19% | +$139K |
|
821
ONE Gas
OGS
$5.05B
| $910K | 0.01% |
14,228
+4,091
| +40% | +$248K |
|
822
Pebblebrook Hotel Trust
PEB
$2.16B
| $908K | 0.01% |
30,511
+7,346
| +32% | +$204K |
|
|
SGYP
823
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $901K | 0.01% |
148,026
+16,916
| +13% | +$88.4K |
|
824
Hanover Insurance
THG
$7.63B
| $900K | 0.01% |
9,886
+819
| +9% | +$68.3K |
|
825
Avient
AVNT
$3.45B
| $898K | 0.01% |
28,027
+6,899
| +33% | +$222K |
|
Similar funds
ProShare Advisors's Q4 2016 Portfolio in Review
As of Q4 2016, ProShare Advisors held 1,787 positions worth $9.03B, up 26% from $7.16B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
ProShare Advisors deployed $1.68B of net new capital in Q4 2016, opening 329 new positions and adding to 1,367 existing holdings. Its largest new stake was Opko Health: 373,523 shares worth $3.47M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Linear Technology Corp, an estimated $2M trimmed.
- ProShare Advisors's largest Q4 2016 buy was Opko Health: 373,523 shares worth $3.47M.
- ProShare Advisors added most to Apple in Q4 2016, an estimated $58.9M increase.
- ProShare Advisors's biggest Q4 2016 reduction was Linear Technology Corp, cutting an estimated $2M.
- ProShare Advisors fully exited Post Properties in Q4 2016, selling an estimated $1.06M.
- ProShare Advisors's ten largest holdings make up 14% of its $9.03B portfolio in Q4 2016.
- ProShare Advisors opened 329 new positions and closed 46 in Q4 2016.
- ProShare Advisors's portfolio value rose 26% quarter-over-quarter to $9.03B.
Based on ProShare Advisors's 13F filing for Q4 2016, filed 13 Feb 2017.